Maghemite (γ-Fe2O3) nanoparticles were obtained by coprecipitation of ferrous and ferric salts in an alkaline medium followed by oxidation; the nanoparticles were coated with poly(N,N-dimethylacrylamide) (PDMA) and characterized by transmission electron microscopy, attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering, thermogravimetric and elemental analyses, and magnetic measurements in terms of particle morphology, size, polydispersity, amount of coating, and magnetization, respectively. The effects of α-tocopherol (Toc) and its phenolic (Toc-6-OH) and acetate (Toc-6-Ac) derivatives on Fe2+ release from γ-Fe2O3@PDMA, as well as from γ-Fe2O3 and CuFe2O4 nanoparticles (controls), were examined in vitro using 1,10-phenanthroline. The presence of tocopherols enhanced spontaneous Fe2+ release from nanoparticles, with Toc-6-OH exhibiting more activity than neat Toc. All of the nanoparticles tested were found to initiate blood lipid oxidation in a concentration-dependent manner, as determined by analysis of 2-thiobarbituric acid reactive species. Wistar rats with Walker-256 carcinosarcoma (a model of mammary gland carcinosarcoma) received Toc-6-Ac, magnetic nanoparticles, or their combination per os, and the antitumor activity of each treatment was determined in vivo. γ-Fe2O3@PDMA nanoparticles exhibited increased antitumor activity compared to both commercial CuFe2O4 particles and the antitumor drug doxorubicin. Moreover, increased antitumor activity was observed after combined administration of γ-Fe2O3@PDMA nanoparticles and Toc-6-Ac; however, levels of bilirubin, aspartate aminotransferase, and white bloods normalized and did not differ from those of the intact controls. The antitumor activity of the γ-Fe2O3 nanoparticles strongly correlated with Fe2+ release from the nanoparticles but not with nanoparticle-initiated lipid peroxidation in vitro.

Department of Mechanisms of Antitumor Therapy R E Kavetsky Institute of Experimental Pathology Oncology and Radiobiology NASU Ukraine

Department of Polymer Particles Institute of Macromolecular Chemistry AS CR Prague Czech Republic

Department of Vitamins and Coenzyme Biochemistry Palladin Institute of Biochemistry NASU Ukraine

See more in PubMed

Lozovska YV, Naleskina LA, Lukyanova NY, Todor IM, Chekhun VF. Assessment of the geno- and cytotoxic action of colloidal gold nano-particles on the bone marrow erythroid cell lines and tumors in animals with Ehrlich ascites carcinoma. Cytol Genet. 2015;49(1):42–48.

Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18):3995–4021. PubMed

Bui DT, Nicolas J, Maksimenko A, Desmaële D, Couvreur P. Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy. Chem Commun (Camb) 2014;50(40):5336–5338. PubMed

Ma P, Mumper RJ. Paclitaxel nano-delivery systems: A comprehensive review. J Nanomed Nanotechnol. 2013;4(2):1000164. PubMed PMC

Schwertmann U, Cornell RM. Iron Oxides in the Laboratory: Preparation and Characterization. Weinheim: WILEY-VCH; 1991.

Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112(11):5818–5878. PubMed

Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1–2):24–46. PubMed

Mao X, Sun H, He X, Chen L, Zhang Y. Well-defined sulfamethazine-imprinted magnetic nanoparticles via surface-initiated atom transfer radical polymerization for highly selective enrichment of sulfonamides in food samples. Anal Methods. 2015;7(11):4708–4716.

Rho WY, Kim HM, Kyeong S, et al. Facile synthesis of monodispersed silica-coated magnetic nanoparticles. J Ind Eng Chem. 2014;20(5):2646–2649.

Konwarh R, Saikia JP, Karak N, Konwar BK. “Poly(ethylene glycol)-magnetic nanoparticles-curcumin” trio: Directed morphogenesis and synergistic free-radical scavenging. Colloids Surf B Biointerfaces. 2010;81(2):578–586. PubMed

Mahmoudi M, Simchi A, Imani M. Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles. J Phys Chem C. 2009;113(22):9573–9580.

Mosaiab T, Jeong CJ, Shin GJ, et al. Recyclable and stable silver deposited magnetic nanoparticles with poly(vinyl pyrrolidone)-catechol coated iron oxide for antimicrobial activity. Mater Sci Eng C Mater Biol Appl. 2013;33(7):3786–3794. PubMed

Fresnais J, Yan M, Courtois J, Bostelmann T, Bée A, Berret JF. Poly(acrylic acid)-coated iron oxide nanoparticles: quantitative evaluation of the coating properties and applications for the removal of a pollutant dye. J Colloid Interface Sci. 2013;395:24–30. PubMed

Bach LG, Islam MR, Kim JT, Seo SY, Lim KT. Encapsulation of Fe3O4 magnetic nanoparticles with poly(methyl methacrylate) via surface functionalized thiol-lactam initiated radical polymerization. Appl Surf Sci. 2012;258(7):2959–2966.

Chen JP, Yang PC, Ma YH, Wu T. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohydr Polym. 2011;84(1):364–372.

Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics and therapy. Acc Chem Res. 2011;44(10):842–852. PubMed PMC

Kim DK, Mikhaylova M, Wang FH, et al. Starch-coated superparamagnetic nanoparticles as MR contrast agents. Chem Mat. 2003;15(23):4343–4351.

Arias JL, López-Viota M, López-Viota J, Delgado AV. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. Int J Pharm. 2009;382(1–2):270–276. PubMed

Iwaki Y, Kawasaki H, Arakawa R. Human serum albumin-modified Fe3O4 magnetic nanoparticles for affinity-SALDI-MS of small-molecule drugs in biological liquids. Anal Sci. 2012;28(9):893–900. PubMed

Gaihre B, Khil MS, Lee DR, Kim HY. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: Drug loading and in vitro drug release study. Int J Pharm. 2009;365(1–2):180–189. PubMed

Donchenko GV, Kholodova YD, Kuzmenko IV, Klymenko KP. Inhibitor of cancer growth. UA 23977. Ukrainian Patent. 1998

Constantinidesa PP, Tustianb A, Kessler DR. Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev. 2004;56(9):1243–1255. PubMed

Schwarz K, Huang SW, German JB, Tiersch B, Hartmann J, Frankel EN. Activities of antioxidants are affected by colloidal properties of oil-in-water and water-in-oil emulsions and bulk oils. J Agric Food Chem. 2000;48(10):4874–4882. PubMed

Yoo SH, Song YB, Chang PS, Lee HG. Microencapsulation of α-tocopherol using sodium alginate and its controlled release properties. Int J Biol Macromol. 2006;38(1):25–30. PubMed

Lambert KJ, Panayiotis PC, Quay SC. Emulsion vehicle for poorly soluble drugs. US 6458373. United States patent. 2002 Oct 1;

Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175–186. PubMed

Hobbs HK, Huffaker JE, Taggart EM, Papas AM. Water dispersible vitamin E composition. US 5234695. United States patent. 1993 Oct 8;

Tan YF, Chandrasekharan P, Maity D, et al. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly(lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles. Biomaterials. 2011;32(11):2969–2978. PubMed

Covaliu CI, Matei C, Litescu S, et al. Radical scavenger properties of oxide nanoparticles stabilized with biopolymer matrix. Mater Plast. 2010;47(1):5–10.

Babič M, Horák D, Jendelová P, et al. Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. Bioconjug Chem. 2009;20(2):283–294. PubMed

Zasonska BA, Boiko N, Horák D, et al. The use of hydrophilic poly(N,N-dimethylacrylamide) grafted from magnetic γ-Fe2O3 nanoparticles to promote engulfment by mammalian cells. J Biomed Nanotechnol. 2012;9:479–491. PubMed

Zuo Y, Hoigné J. Formation of hydrogen peroxide and depletion of oxalic acid in atmospheric water by photolysis of iron(III)-oxalato complexes. Environ Sci Technol. 1992;26(5):1014–1022.

Walters MI, Gerarde HW. An ultramicromethod for the determination of conjugated and total bilirubin in serum or plasma. Microchem J. 1970;15(2):231–243.

Henley KS. IFCC method for alanine aminotransferase. Clin Chim Acta. 1980;105(1):155–166. PubMed

Bergmeyer HU, Horder M, Moss DW. Provisional recommendations on IFCC methods for the measurements of catalytic concentrations of enzymes. Part 3. Revised IFCC method for aspartate aminotransferase. Clin Chem. 1978;24:720–721. PubMed

Gelvan D, Saltman P. Different cellular targets for Cu and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbituric acid assay. Biochim Biophys Acta. 1990;1035(3):353–360. PubMed

Ke W, Zhao Y, Huang R, Jiang C, Pei Y. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J Pharm Sci. 2008;97(6):2208–2216. PubMed

Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, et al. Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY) 2013;42(6):217–224. PubMed

Close B, Banister K, Baumans V, et al. Recommendations for euthanasia of experimental animals: Part 1. DGXT of the European Commission. Lab Anim. 1996;30(4):293–316. PubMed

Close B, Banister K, Baumans V, et al. Recommendations for euthanasia of experimental animals: Part 2. DGXT of the European Commission. Lab Anim. 1997;31(1):1–32. PubMed

Babič M, Horák D, Trchová M, et al. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem. 2008;19(3):740–750. PubMed

Pirri G, Damin F, Chiari M, Bontempi E, Depero LE. Characterization of a polymeric adsorbed coating for DNA microarray glass slides. Anal Chem. 2004;76(5):1352–1358. PubMed

Horák D, Semenyuk N, Lednický F. Effect of the reaction parameters on the particle size in the dispersion polymerization of 2-hydroxyethyl and glycidyl methacrylate in the presence of a ferrofluid. J Polym Sci Polym Chem. 2003;41(12):1848–1863.

Hermanson GT, Malia AK, Smith PK. Immobilized Affinity Ligand Techniques. San Diego: Academic Press Inc; 1992.

Yang J, Kopeček J. Backbone degradable and coiled-coil based macromolecular therapeutics. In: Gu Z, editor. Bioinspired and Biomimetic Polymer Systems for Drug and Gene Delivery. Weinheim: Wiley-WCH; 2015.

McConnel EL, Basit AW, Murdan S. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissues, and implications for in-vivo experiments. J Pharm Pharmacol. 2007;60(1):63–70. PubMed

Emmerie A, Engel C. Colorimetric determination of tocopherol (vitamin E). III. Estimation of tocopherol in blood serum. Rec Trav Chim. 1939;58(10):895–902.

Mizushima Y, Takama K, Zama K. Effect of copper, iron and hemin on lipid oxidation in fish flesh homogenate. Bull Fac Fish Hokkaido Univ. 1977;28(4):207–211.

Lauridsen C, Hedemann MS, Jensen SK. Hydrolysis of tocopheryl and retinyl esters by porcine carboxyl ester hydrolase is affected by their carboxylate moiety and bile acids. J Nutr Biochem. 2001;12(4):219–224. PubMed

Muller DP, Manning JA, Mathias PM, Harries JT. Studies on the intestinal hydrolysis of tocopheryl esters. Int J Vitam Nutr Res. 1976;46:207–210. PubMed

Macková H, Horák D, Donchenko GV, et al. Colloidally stable surface-modified iron oxide nanoparticles: Preparation, characterization and anti-tumor activity. J Magn Magn Mater. 2015;380:125–131.

Torti SV, Torti FM. Iron and cancer: More ore to be mined. Nat Rev Cancer. 2013;13(5):342–355. PubMed PMC

Mojžišová G, Mojžiš J, Vašková J. Organometallic iron complexes as potential cancer therapeutics. Acta Biochim Pol. 2014;61(4):651–654. PubMed

Ludwig H, Evstatiev R, Kornek G, et al. Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr. 2015;127(23–24):907–919. PubMed PMC

Zhu MT, Wang Y, Feng WY, et al. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. J Nanosci Nanotechnol. 2010;10(2):8584–8590. PubMed

Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc Trans. 1894;65:899–911.

Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011;434(3):365–381. PubMed PMC

Voinov MA, Sosa Pagán JO, Morrison E, Smirnova TI, Smirnov AI. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J Am Chem Soc. 2011;133(1):35–41. PubMed

Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557–570. PubMed PMC

Hughes MF, Long TC, Boyes WK, Ramabhadran R. Whole-body retention and distribution of orally administered radiolabeled zerovalent iron nanoparticles in mice. Nanotoxicology. 2013;7(6):1064–1069. PubMed

Singh SP, Rahman MF, Murty US, Mahboob M, Grover P. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol Appl Pharmacol. 2013;266(1):56–66. PubMed

Duncan R, Sat YN. Tumour targeting by enhanced permeability and retention (EPR) effect. Ann Oncol. 1998;9(Suppl 2):39.

Zhang Q, Rajan SS, Tyner KM, et al. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells. J Biomed Mater Res B Appl Biomater. 2016;104(5):1032–1042. PubMed

Gao H, Yang Z, Zhang S, et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep. 2013;3:2534. PubMed PMC

Raoof M, Mackeyev Y, Cheney MA, Wilson LJ, Curley SA. Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex. Biomaterials. 2012;33(10):2952–2960. PubMed PMC

Xu C, Yuan Z, Kohler N, Kim J, Chung MA, Sun S. FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition. J Am Chem Soc. 2009;131(42):15346–15351. PubMed PMC

Li L, Jiang W, Luo K, et al. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics. 2013;3(8):595–615. PubMed PMC